Tore Lind - MD, PH.D, AstraZeneca Research and Development, Mölndal (1980-2004); Senior Medical Advisor Isofol Medical AB, Gothenburg (from mid 2004), Sweden.
He is an upper G.I. surgeon by training and was an external advisor to AstraZeneca from 1980 to 2000 where he was closely involved in the development of
Losec and
Nexium.